WallStreetZenWallStreetZen

NASDAQ: PASG
Passage Bio Inc Stock Ownership - Who owns Passage Bio?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Passage Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kathleen BorthwickCFO2026-01-082,062$18.44
$38.02kSell
William ChouPRESIDENT AND CEO2026-01-084,076$18.44
$75.16kSell
Lynx1 Capital Management LP10% Owner2025-09-1511,900$6.99
$83.17kBuy
Lynx1 Capital Management LP10% Owner2025-09-1219,783$6.99
$138.30kBuy
Lynx1 Capital Management LP10% Owner2025-09-11325$6.96
$2.26kBuy
Lynx1 Capital Management LP10% Owner2025-07-2466,423$5.71
$379.47kBuy
Lynx1 Capital Management LP10% Owner2025-07-2349,302$5.74
$283.04kBuy
Lynx1 Capital Management LP10% Owner2025-07-2213,123$5.44
$71.34kBuy
Orbimed Advisors LLC10% Owner2025-06-26213,257$0.33
$70.37kSell
Orbimed Advisors LLC10% Owner2025-06-25138,800$0.33
$45.80kSell

1 of 2

PASG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PASG insiders and whales buy or sell their stock.

PASG Shareholders

What type of owners hold Passage Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC374.51%12,013,666$89.26MInsider
Frazier Life Sciences IX LP156.16%5,009,219$37.22MInsider
Patrick J. Heron156.16%5,009,219$37.22MInsider
Thomas Woiwode154.62%4,959,769$36.85MInsider
Versant Venture Capital VI LP154.62%4,959,769$36.85MInsider
Liam Ratcliffe81.66%2,619,430$19.46MInsider
Stephen P. Squinto20.84%668,575$4.97MInsider
Tadataka Yamada20.45%656,149$4.88MInsider
Lynx1 Capital Management LP19.44%623,704$4.63MInsider
Lynx1 Capital Management LP19.44%623,704$4.63MInstitution

1 of 3

PASG vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PASG4.08%95.92%Net SellingNet Selling
LGVN4.40%71.83%Net SellingNet Selling
TVGN3.05%96.95%Net SellingNet Selling
MRKR2.85%97.15%
SNTI17.99%82.01%
View Top Biotech Stocks

Passage Bio Stock Ownership FAQ

Who owns Passage Bio?

Passage Bio (NASDAQ: PASG) is owned by 49.17% institutional shareholders, 1,156.54% Passage Bio insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Passage Bio shareholder, owning 12.01M shares representing 374.51% of the company. Orbimed Advisors LLC's Passage Bio shares are currently valued at $84.58M.

If you're new to stock investing, here's how to buy Passage Bio stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.